{"id":162918,"date":"2023-04-27T22:23:46","date_gmt":"2023-04-28T03:23:46","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/04\/what-ai-technology-is-doing-for-longevity-now"},"modified":"2023-04-27T22:23:46","modified_gmt":"2023-04-28T03:23:46","slug":"what-ai-technology-is-doing-for-longevity-now","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/04\/what-ai-technology-is-doing-for-longevity-now","title":{"rendered":"What AI Technology Is Doing for Longevity Now"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/what-ai-technology-is-doing-for-longevity-now.jpg\"><\/a><\/p>\n<p>In March 2023, MIT Technology Review revealed that Sam Altman, the CEO of OpenAI (ChatGPT), was the mystery investor behind the $180 million investment into stealth startup Retro Biosciences, a biotech company with the ambition of \u201cadding 10 years to the human lifespan.\u201d This investment marks the latest tech entrepreneur expressing their interest in longevity science and a new connection with innovative AI technology.<\/p>\n<p>According to February 2023 <a href=\"https:\/\/www.researchandmarkets.com\/reports\/5116503\/global-artificial-intelligence-in-healthcare?\">reports<\/a>, AI is continuing to gain traction in healthcare applications. Currently, the market is estimated at $14.6 billion (USD) with a compound annual growth rate (CAGR) of 47.6%, with solutions spread across various healthcare fields, such as patient data and risk analysis, precision medicine, cybersecurity, lifestyle management, and drug discovery.<\/p>\n<p>The increasing convergence of AI technology and longevity science is sparking advancements in the sector, with established businesses, start-ups, and researchers utilizing the technology. Most recently, scientists explored how ChatGPT, an AI-based language model, was able to predict Alzheimer\u2019s in <a href=\"https:\/\/journals.plos.org\/digitalhealth\/article?id=10.1371\/journal.pdig.0000168\">80%<\/a> of cases when analyzing speech. However, it is not the only implementation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In March 2023, MIT Technology Review revealed that Sam Altman, the CEO of OpenAI (ChatGPT), was the mystery investor behind the $180 million investment into stealth startup Retro Biosciences, a biotech company with the ambition of \u201cadding 10 years to the human lifespan.\u201d This investment marks the latest tech entrepreneur expressing their interest in longevity [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,34,269,6],"tags":[],"class_list":["post-162918","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-cybercrime-malcode","category-life-extension","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/162918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=162918"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/162918\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=162918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=162918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=162918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}